http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010042210-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-46 |
| filingDate | 1999-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20010042210-A |
| titleOfInvention | Preventives/remedies for urinary disorder |
| abstract | The present invention is formula (I)n n n [Formula I]n n n n n n n n [Wherein, Ring A represents phenyl substituted with hydroxy (lower alkyl); Ring B represents phenyl substituted with lower alkyl; Alk represents lower alkyl; R contains an optionally substituted nitrogen-containing aromatic heterocyclic monocyclic group or a pharmacologically acceptable salt thereof as an active ingredient, and exhibits an excellent inhibitory effect on the increase in urethral resistance caused by endothelin Provided are novel prophylactic / therapeutic agents useful for the prophylaxis and treatment of urinary disorders related to Tellin. |
| priorityDate | 1998-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.